Xintela AB
Developing stem cell and targeted cancer therapies for unmet needs.
Overview
- 10–19
- Employees
- 2.5–5M SEK
- Revenue
- 2009
- Founded
Key Decision Makers
Lars Hedbys
Board member
Evy Lundgren-Åkerlund
Chief Executive Officer
Maarten de Château
Board member
Gunnar Telhammar
CFO
+9 more contacts in Funnelfeedr
Description
Xintela is a Swedish biopharmaceutical company focused on developing innovative treatments in stem cell therapy and targeted cancer therapy. The organization aims to address significant unmet medical needs in areas like osteoarthritis and aggressive cancers. Its core stem cell product, XSTEM®, is be...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556780348001
Decision Makers
13 contacts in FunnelfeedrLars Hedbys
Board member
Evy Lundgren-Åkerlund
Chief Executive Officer
Maarten de Château
Board member
Gunnar Telhammar
CFO
Peter Ekolind
COO & VP Commercial Manufacturing
Hans-Joachim Simons
BOARD MEMBER
Gregory Batcheller
Chairman of the Board
Lucienne Vonk
CSO
Carl-Magnus Högerkorp
Head of Research
Thomas Eldered
BOARD MEMBER
Liselotte Theorell
DIRECTOR QUALITY MANAGEMENT, QP
Camilla Wennersten
DIRECTOR CLINICAL DEVELOPMENT
Other Contacts
Folke Sjöberg
Professor
Similar Companies
20 similar companies in Funnelfeedr
Targinta AB
0 employeesDeveloping targeted antibodies and ADCs for aggressive cancers.
Synartro AB
1–4 employeesDeveloping sustained local injection treatments for osteoarthritis pain relief.
Procella Therapeutics AB
45 employeesBiotech developing precision delivery platforms and advanced cell therapies.
PILA PHARMA AB
1–4 employeesClinical stage biotech developing an oral obesity and diabetes treatment.
NextCell Pharma AB
Developing pioneering cell therapies for autoimmune diseases and diabetes.
Browse More
Xintela AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo